中芯國際(0981.HK)高開3.35% 擬合作開展28納米及以上集成電路項目
格隆匯8月3日丨中芯國際(0981.HK)高開3.35%報30.85港元,盤前成交8638萬港元,最新總市值3312億港元。A股目前集合競價漲4%。公司7月31日晚正式公告,將與北京開發區管委會訂立合作框架文件,擬成立合資企業合作開展28納米及以上集成電路項目。據悉,該合資企業項目將聚焦於生產28納米及以上集成電路,首期投資額高達76億美元,首期目標達到每月約10萬片的產能。此外,初始註冊資本也高達50億美元,並且約51%的初始註冊資本由中芯國際出資。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.